Edition:
India

People: Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

51.22USD
13 Sep 2019
Change (% chg)

$-1.36 (-2.59%)
Prev Close
$52.58
Open
$52.58
Day's High
$52.68
Day's Low
$51.10
Volume
111,126
Avg. Vol
187,967
52-wk High
$64.48
52-wk Low
$31.98

Munshi, Amit 

Mr. Amit D. Munshi serves as Director, President and Chief Executive Officer of the Company. He has served as a member of our Board of Directors since June 2016, and as our President and Chief Executive Officer since May 2016. Previously, Mr. Munshi served as President and Chief Executive Officer and a director of Epirus Biopharmaceuticals, Inc. from May 2012 to May 2016, and as Chief Executive Officer of Percivia LLC, a biotechnology company, from 2011 to 2012. Prior to Epirus and Percivia, Mr. Munshi was a co-founder and served as Chief Business Officer of Kythera Biopharmaceuticals, Inc., from 2005 to 2010, and held multiple leadership positions at Amgen Inc. from 1997 to 2005, including General Manager, Nephrology Europe. In July 2016, Epirus filed a voluntary Chapter 7 petition in the United States Bankruptcy Court for the District of Massachusetts. Mr. Munshi holds a B.S. in Economics and a B.A. in History from the University of California, Riverside, and an M.B.A. from the Peter F. Drucker School of Management at Claremont Graduate University. Mr. Munshi has more than 28 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Mr. Munshi currently serves on the board of Pulmatrix, Inc., a biopharmaceutical company developing inhaled therapies to address pulmonary diseases, and also serves as an advisor and lecturer at the Peter F. Drucker School of Management at the Claremont Graduate School.

Basic Compensation

Total Annual Compensation, USD 1,110,620
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 5,752,820
Fiscal Year Total, USD 6,863,440

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tina Nova

361,363

Amit Munshi

6,863,440

Kevin Lind

3,061,040

Steven Spector

3,112,620

Vincent Aurentz

3,163,930

Preston Klassen

3,079,840
As Of  31 Dec 2018